TY - JOUR
T1 - A systematic review of Radiesse/calcium hydroxylapatite and carboxymethylcellulose
T2 - evidence and recommendations for treatment of the face
AU - Guida, Stefania
AU - Galadari, Hassan
N1 - Publisher Copyright:
© 2023 the International Society of Dermatology.
PY - 2024/2
Y1 - 2024/2
N2 - Radiesse® is a filler composed of calcium hydroxylapatite microspheres suspended in a carboxymethylcellulose gel (CaHA/CMC). It has robust rheological properties that have been associated with its versatility. CaHA/CMC is employed for both on-label indications of filling wrinkles or lines, volumizing, and contouring of areas as well as off-label indications aiming at biostimulation and skin tightening. However, despite the expanding use of CaHA/CMC, overall evidence and recommendations for treatment are currently lacking. This paper aims to provide an up-to-date overview of CaHA/CMC clinical applications, together with a level of evidence of supporting literature, focusing on the face. Based on the data, CaHA/CMC may be considered a safe and effective treatment option for cheeks, jawline, HIV-related facial lipoatrophy, and nasolabial folds. Treatment of marionette lines, chin, pre-jowl, and corner of the mouth also tends to respond with a high degree of efficacy. Despite the recent trend, guidelines, and safety profile of diluted and hyperdiluted Radiesse®, no randomized controlled trials have been published.
AB - Radiesse® is a filler composed of calcium hydroxylapatite microspheres suspended in a carboxymethylcellulose gel (CaHA/CMC). It has robust rheological properties that have been associated with its versatility. CaHA/CMC is employed for both on-label indications of filling wrinkles or lines, volumizing, and contouring of areas as well as off-label indications aiming at biostimulation and skin tightening. However, despite the expanding use of CaHA/CMC, overall evidence and recommendations for treatment are currently lacking. This paper aims to provide an up-to-date overview of CaHA/CMC clinical applications, together with a level of evidence of supporting literature, focusing on the face. Based on the data, CaHA/CMC may be considered a safe and effective treatment option for cheeks, jawline, HIV-related facial lipoatrophy, and nasolabial folds. Treatment of marionette lines, chin, pre-jowl, and corner of the mouth also tends to respond with a high degree of efficacy. Despite the recent trend, guidelines, and safety profile of diluted and hyperdiluted Radiesse®, no randomized controlled trials have been published.
UR - http://www.scopus.com/inward/record.url?scp=85174891148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174891148&partnerID=8YFLogxK
U2 - 10.1111/ijd.16888
DO - 10.1111/ijd.16888
M3 - Review article
C2 - 37897174
AN - SCOPUS:85174891148
SN - 0011-9059
VL - 63
SP - 150
EP - 160
JO - International Journal of Dermatology
JF - International Journal of Dermatology
IS - 2
ER -